PT1001944E - Derivados de pirazina sua preparacao e os medicamentos que os contem - Google Patents
Derivados de pirazina sua preparacao e os medicamentos que os contemInfo
- Publication number
- PT1001944E PT1001944E PT98939676T PT98939676T PT1001944E PT 1001944 E PT1001944 E PT 1001944E PT 98939676 T PT98939676 T PT 98939676T PT 98939676 T PT98939676 T PT 98939676T PT 1001944 E PT1001944 E PT 1001944E
- Authority
- PT
- Portugal
- Prior art keywords
- ch2oh
- alk
- choh
- equal
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9709058A FR2766187B1 (fr) | 1997-07-17 | 1997-07-17 | Derives de pyrazine, leur preparation et les medicaments les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1001944E true PT1001944E (pt) | 2004-02-27 |
Family
ID=9509300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98939676T PT1001944E (pt) | 1997-07-17 | 1998-07-15 | Derivados de pirazina sua preparacao e os medicamentos que os contem |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6399613B1 (pt) |
| EP (1) | EP1001944B1 (pt) |
| JP (1) | JP4443036B2 (pt) |
| KR (1) | KR20010021901A (pt) |
| CN (1) | CN1264371A (pt) |
| AT (1) | ATE251144T1 (pt) |
| AU (1) | AU747127B2 (pt) |
| BR (1) | BR9810880A (pt) |
| CA (1) | CA2296727C (pt) |
| DE (1) | DE69818679T2 (pt) |
| DK (1) | DK1001944T3 (pt) |
| ES (1) | ES2205536T3 (pt) |
| FR (1) | FR2766187B1 (pt) |
| HU (1) | HUP0004602A3 (pt) |
| IL (1) | IL134040A0 (pt) |
| MX (1) | MXPA00000280A (pt) |
| NO (1) | NO20000198D0 (pt) |
| NZ (1) | NZ501906A (pt) |
| PL (1) | PL338148A1 (pt) |
| PT (1) | PT1001944E (pt) |
| RU (1) | RU2194703C2 (pt) |
| SK (1) | SK482000A3 (pt) |
| WO (1) | WO1999003844A1 (pt) |
| ZA (1) | ZA986337B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9905771D0 (en) * | 1999-03-12 | 1999-05-05 | Isis Innovation | Compounds |
| US7598278B2 (en) * | 2002-04-11 | 2009-10-06 | L'oreal | Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss |
| US20070270590A1 (en) * | 2006-04-20 | 2007-11-22 | Marioara Mendelovici | Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
| EP1904499A1 (en) * | 2006-06-26 | 2008-04-02 | Teva Pharmaceutical Industries Ltd | Process for the preparation of zopiclone |
| TW200846340A (en) * | 2007-01-31 | 2008-12-01 | Teva Pharma | Methods for preparing eszopiclone |
| CN101891679B (zh) * | 2009-05-19 | 2014-04-16 | 上海华明高技术（集团）有限公司 | 吡啶二甲酸与二氨基吡啶质子转移化合物的制备方法 |
| FR3030248B1 (fr) | 2014-12-22 | 2018-03-23 | L'oreal | Association derive d'acide pyridine-dicarboxylique/agent anti-oxydant particulier |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4220650A (en) * | 1978-10-18 | 1980-09-02 | Pfizer Inc. | Organic diamine therapeutic compositions and methods |
| DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| JPH01117863A (ja) * | 1987-10-30 | 1989-05-10 | Toyobo Co Ltd | 新規なアミド化合物 |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
-
1997
- 1997-07-17 FR FR9709058A patent/FR2766187B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-15 HU HU0004602A patent/HUP0004602A3/hu unknown
- 1998-07-15 MX MXPA00000280A patent/MXPA00000280A/es unknown
- 1998-07-15 PT PT98939676T patent/PT1001944E/pt unknown
- 1998-07-15 NZ NZ501906A patent/NZ501906A/en unknown
- 1998-07-15 DK DK98939676T patent/DK1001944T3/da active
- 1998-07-15 RU RU2000103449/04A patent/RU2194703C2/ru not_active IP Right Cessation
- 1998-07-15 AT AT98939676T patent/ATE251144T1/de not_active IP Right Cessation
- 1998-07-15 WO PCT/FR1998/001542 patent/WO1999003844A1/fr not_active Application Discontinuation
- 1998-07-15 DE DE69818679T patent/DE69818679T2/de not_active Expired - Lifetime
- 1998-07-15 SK SK48-2000A patent/SK482000A3/sk unknown
- 1998-07-15 IL IL13404098A patent/IL134040A0/xx unknown
- 1998-07-15 CA CA002296727A patent/CA2296727C/fr not_active Expired - Fee Related
- 1998-07-15 ES ES98939676T patent/ES2205536T3/es not_active Expired - Lifetime
- 1998-07-15 EP EP98939676A patent/EP1001944B1/fr not_active Expired - Lifetime
- 1998-07-15 BR BR9810880-8A patent/BR9810880A/pt not_active IP Right Cessation
- 1998-07-15 KR KR1020007000465A patent/KR20010021901A/ko not_active Application Discontinuation
- 1998-07-15 CN CN98807199A patent/CN1264371A/zh active Pending
- 1998-07-15 PL PL98338148A patent/PL338148A1/xx unknown
- 1998-07-15 AU AU88102/98A patent/AU747127B2/en not_active Ceased
- 1998-07-15 JP JP2000503069A patent/JP4443036B2/ja not_active Expired - Fee Related
- 1998-07-16 ZA ZA986337A patent/ZA986337B/xx unknown
-
2000
- 2000-01-14 US US09/483,984 patent/US6399613B1/en not_active Expired - Fee Related
- 2000-01-14 NO NO20000198A patent/NO20000198D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69818679D1 (de) | 2003-11-06 |
| HUP0004602A2 (hu) | 2001-11-28 |
| NZ501906A (en) | 2002-04-26 |
| EP1001944A1 (fr) | 2000-05-24 |
| DK1001944T3 (da) | 2004-02-09 |
| IL134040A0 (en) | 2001-04-30 |
| WO1999003844A1 (fr) | 1999-01-28 |
| ZA986337B (en) | 1999-01-27 |
| AU8810298A (en) | 1999-02-10 |
| DE69818679T2 (de) | 2004-07-29 |
| HUP0004602A3 (en) | 2001-12-28 |
| CN1264371A (zh) | 2000-08-23 |
| MXPA00000280A (es) | 2002-04-17 |
| US6399613B1 (en) | 2002-06-04 |
| NO20000198L (no) | 2000-01-14 |
| CA2296727C (fr) | 2009-06-09 |
| PL338148A1 (en) | 2000-09-25 |
| FR2766187B1 (fr) | 2000-06-02 |
| RU2194703C2 (ru) | 2002-12-20 |
| CA2296727A1 (fr) | 1999-01-28 |
| EP1001944B1 (fr) | 2003-10-01 |
| ATE251144T1 (de) | 2003-10-15 |
| SK482000A3 (en) | 2000-06-12 |
| FR2766187A1 (fr) | 1999-01-22 |
| NO20000198D0 (no) | 2000-01-14 |
| KR20010021901A (ko) | 2001-03-15 |
| JP2001510188A (ja) | 2001-07-31 |
| BR9810880A (pt) | 2002-05-21 |
| AU747127B2 (en) | 2002-05-09 |
| ES2205536T3 (es) | 2004-05-01 |
| JP4443036B2 (ja) | 2010-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2126068T3 (es) | Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene. | |
| PT83843B (pt) | Processo para a preparacao de promedicamentos de rapamicina | |
| DK0513104T3 (da) | Anvendelse af et alfa-tocopherolphosphat eller et af dets derivater til fremstilling af kosmetiske, dermatologiske eller farmaceutiske præparater, og således opnåede præparater | |
| IE830785L (en) | Pharmaceutical compositions containing oxicam derivatives | |
| FI840635A0 (fi) | Nya karbacykliner, foerfarande foer framstaellning av dem och deras anvaendning som laekemedel | |
| PT1001944E (pt) | Derivados de pirazina sua preparacao e os medicamentos que os contem | |
| ATE109770T1 (de) | Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten. | |
| OA09349A (fr) | "Nouveaux dérivés du 3-aminochromane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
| FR2623504B1 (fr) | Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| ES2096572T3 (es) | Nuevos derivados de glucosidos de antraciclina y procedimiento para su preparacion. | |
| FI932641A (fi) | Nytt estradiolderivat-klorambucil-konjugat, foerfarande foer dess framstaellning och farmaceutiska kompositioner | |
| FI810632L (fi) | 5,6:8,9-tetrahydro-7h-dibenz (d f)azoninderivat deras framstaellning och foereningar innehaollande dem | |
| SE9701912D0 (sv) | Pharmaceutical composition and use thereof | |
| FR2766185B1 (fr) | Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation | |
| BG101942A (en) | Analogues of arginine having inhibiting activity on no-synthetase | |
| TW328083B (en) | New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides | |
| ATE9892T1 (de) | Dibenzocycloheptenylidene und ihre verwendung in pharmazeutischen zusammensetzungen. | |
| YU150690A (sh) | Benzotiazinski derivati i postupak za njihovo dobijanje | |
| ES2061864T3 (es) | Sustancia antitumoral, procedimiento para su preparacion, y agente anticanceroso que la contiene. | |
| OA09299A (fr) | Nouveaux dérivés N- (vincristinoyl-23) et N- (noranhydro-5' vinblastinoyl-23) d'acide animo-1 méthylphosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| ES8300709A1 (es) | Un metodo para la preparacion de derivados de pirazolidinona |